e-ISSN: 2347-7857 p-ISSN: 2347-7849
Articles published in Research & Reviews: Journal of Pharmaceutics and Nanotechnology have been cited by esteemed scholars and scientists all around the world. Research & Reviews: Journal of Pharmaceutics and Nanotechnology has got h-index 10, which means every article in Research & Reviews: Journal of Pharmaceutics and Nanotechnology has got 10 average citations.
Following are the list of articles that have cited the articles published in Research & Reviews: Journal of Pharmaceutics and Nanotechnology.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
24 | 41 | 33 | 16 | 26 | 20 | 20 | 10 | 67 | 35 | 27 |
Research, Review articles and Editorials |
0 | 6 | 9 | 5 | 13 | 15 | 6 | 10 | 18 | 20 | 27 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
15 | 38 | 26 | 10 | 3 | 5 | 14 | 0 | 26 | 13 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
46 | 38 | 42 | 62 | 38 | 48 | 37 | 36 | 22 | 10 | 3 |
Journal total citations count | 307 |
Journal impact factor | 2.09 |
Journal 5 years impact factor | 1.89090909 |
Journal cite score | 1.9 |
Journal h-index | 10 |
Journal h-index since 2019 | 9 |
Journal Impact Factor 2020 formula |
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
Journal 5-year Impact Factor 2020 formula |
Citations(2018 + 2019 + 2020 + 2021 + 2022)/ {Published articles(2018 + 2019 + 2020 + 2021 + 2022)} |
Journal citescore |
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Study of regulatory requirements for the conduct of bioequivalence studies in us, europe, canada, india, asean and sadc countries: impact on generic drug substitution
|
|
A review literature on pharmacology
|
|
Novel drug delivery approach in cancer therapy
|
|
A combinatorial approach involving e. coli cytosine deaminase and 5-fluorocytosine-nanoparticles as an enzyme-prodrug therapeutic method for highly substrate selective in situ generation of 5-fluorouracil
|
|
Conjugation of isoniazid to a zinc phthalocyanine via hydrazone linkage for ph-dependent liposomal controlled release
|
|
Ph-dependent release of isoniazid from isonicotinic acid (4-hydroxy-benzylidene)-hydrazide loaded liposomes
|
|
Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil
|
|
Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes
|
|
Formulation, development and evaluation of nifedipine emulgel for treatment of anal fissures using polymeric emulsifiers
|
|
Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds
|
|
Applications of mesoporous silica in biosensing and controlled release of insulin
|
|
Nanotechnology in wastewater and the capacity of nanotechnology for sustainability
|
|
Visualization of conformational variability in the domains of long single-stranded rna molecules
|
|
Method development, validation and stability studies for determination of bumetanide in bulk and pharmaceutical dosage form by rp-uplc
|
|
Non-imaging and radiopharmacy instrumentation in nuclear medicine
|
|
Photocatalytic removal of parabens and halogenated products in wastewater: a review
|
|
Protein glycosylation in extracellular vesicles: structural characterization and biological functions
|
|
Application of failure mode effect analysis in wurster-based pelletization technology: a technical note.
|
|
Magnetic nano-áomposites and their industrial applications
|
|
Magnetic nano-áomposites and their industrial applications
|
|